Percutaneous septal ablation: a new treatment for hypertrophic obstructive cardiomyopathy.
作者信息
Seggewiss H
出版信息
Neth Heart J. 2001 Nov;9(8):315-317.
Abstract
摘要
相似文献
1
Percutaneous septal ablation: a new treatment for hypertrophic obstructive cardiomyopathy.经皮室间隔消融术：肥厚型梗阻性心肌病的一种新治疗方法。
Neth Heart J. 2001 Nov;9(8):315-317.
2
Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.肥厚性梗阻性心肌病的间隔消融术：经冠状动脉和心内膜途径
Am J Med Sci. 2016 Nov;352(5):466-471. doi: 10.1016/j.amjms.2016.08.025. Epub 2016 Sep 21.
3
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.酒精间隔消融术治疗肥厚型梗阻性心肌病：已发表研究的系统评价
J Interv Cardiol. 2006 Aug;19(4):319-27. doi: 10.1111/j.1540-8183.2006.00153.x.
4
B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation.经皮腔内室间隔心肌消融术后的B型利钠肽
Int J Cardiol. 2002 May;83(2):151-8. doi: 10.1016/s0167-5273(02)00035-9.
5
Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.通过右上间隔动脉对肥厚型梗阻性心肌病患者成功进行经皮腔内间隔心肌消融术。
Cardiovasc Interv Ther. 2015 Oct;30(4):377-81. doi: 10.1007/s12928-014-0310-4. Epub 2014 Dec 13.
6
[One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].肥厚型梗阻性心肌病经超声心动图引导的经皮室间隔消融术后一年随访
Dtsch Med Wochenschr. 2001 Apr 12;126(15):424-30. doi: 10.1055/s-2001-12731.
7
8
[Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].经胸超声心动图引导下经皮心肌间隔射频消融术治疗梗阻性肥厚型心肌病患者的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Apr 24;47(4):284-290. doi: 10.3760/cma.j.issn.0253-3758.2019.04.005.
9
Quantitative analysis of intraprocedural myocardial contrast echocardiography during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy.
Eur J Echocardiogr. 2004 Dec;5(6):443-8. doi: 10.1016/j.euje.2004.04.003.
10
[Left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation: an echocardiographic study].经皮酒精室间隔消融治疗肥厚性梗阻性心肌病患者的左心室重构：一项超声心动图研究
Rev Esp Cardiol. 2003 Dec;56(12):1174-81. doi: 10.1016/s0300-8932(03)77035-3.
引用本文的文献
1
A case of ventricular asystole without escape rhythm 4 days after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy with drug-resistant paroxysmal atrial fibrillation.肥厚型梗阻性心肌病伴药物难治性阵发性心房颤动患者经皮腔内室间隔心肌消融术后4天出现无逸搏心律的心室停搏1例。
J Cardiol Cases. 2011 Aug 11;4(2):e110-e114. doi: 10.1016/j.jccase.2011.07.002. eCollection 2011 Oct.
本文引用的文献
1
Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.经皮室间隔消融术治疗肥厚型心肌病和心室中部梗阻。
Eur J Echocardiogr. 2000 Dec;1(4):277-80. doi: 10.1053/euje.2000.0032.
2
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.术中心肌对比超声心动图作为经皮腔内室间隔心肌消融术的常规操作：检测远离室间隔靶区域的潜在心肌坏死
Catheter Cardiovasc Interv. 1999 Aug;47(4):462-6. doi: 10.1002/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9.
3
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病的经皮腔内室间隔消融术
Thorac Cardiovasc Surg. 1999 Apr;47(2):94-100. doi: 10.1055/s-2007-1013118.
4
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.美国某地区队列中肥厚型心肌病的临床病程
JAMA. 1999 Feb 17;281(7):650-5. doi: 10.1001/jama.281.7.650.
5
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术：关于术中心肌对比超声心动图的结果
Circulation. 1998 Dec 1;98(22):2415-21. doi: 10.1161/01.cir.98.22.2415.
6
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.心肌对比超声心动图在肥厚型梗阻性心肌病非手术性室间隔减容治疗中的作用。
J Am Coll Cardiol. 1998 Jul;32(1):225-9. doi: 10.1016/s0735-1097(98)00220-4.
7
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病：25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
8
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.肥厚型梗阻性心肌病的非手术性室间隔减容术：首批患者的治疗结果
Circulation. 1997 Apr 15;95(8):2075-81. doi: 10.1161/01.cir.95.8.2075.
9
The management of hypertrophic cardiomyopathy.肥厚型心肌病的管理
N Engl J Med. 1997 Mar 13;336(11):775-85. doi: 10.1056/NEJM199703133361107.
10
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病的非手术性心肌减容术
Lancet. 1995 Jul 22;346(8969):211-4. doi: 10.1016/s0140-6736(95)91267-3.
Zotero 插件